Life Science Company
Jazz Pharmaceuticals has acquired 5 companies, including 2 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 1 asset.
Jazz Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired Celator Pharmaceuticals for $1.5B. Jazz Pharmaceuticals has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Jazz Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity5
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 4
- M&A Advisors 4
Unlimited Searches
